01-29-2013 New Pre-Clinical and Clinical Data on GeNO, LLC's Nitric Oxide Delivery Systems to be Presented at 2013 American College of Cardiology and American Thoracic Society Medical Meetings.
12-18-2012 GeNO, LLC Announces Senior Management Appointments. Dasse Named President; Gellman Named Senior Vice President, Engineering.
11-13-2012 FDA Accepts GeNO, LLC Filing of New Drug Application for GeNOsylTM MVG-2000 Nitric Oxide Delivery System.
08-21-2012 GeNO, LLC Receives Four Additional Patents for Inhaled Nitric Oxide Delivery. 16 US Patents Protect Key Chemistry.